The study pooled shotgun metagenomic data from multiple countries and found that Parkinson’s disease (PD) is consistently associated with higher gut microbial diversity, increased Akkermansia, and reduced SCFA-producing bacteria like Roseburia and Faecalibacterium. Functionally, PD guts showed a strong loss of microbial genes for riboflavin (B2) and biotin (B7) synthesis and reduced carbohydrate-metabolizing enzymes, indicating impaired microbial metabolism. Fecal metabolomics confirmed lower SCFAs and polyamines. The authors propose that reduced microbial vitamin synthesis → reduced SCFAs/polyamines → weakened gut barrier → increased inflammation and α-synuclein aggregation in gut nerves, forming a mechanistic pathway linking gut dysbiosis to Parkinson’s disease.